News
08-17-2010, 05:51 AM
Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
More... (http://www.news-medical.net/news/20100817/Chronix-Biomedical-expands-biomarker-development-capabilities-with-installation-of-DNA-mass-sequencer.aspx)
More... (http://www.news-medical.net/news/20100817/Chronix-Biomedical-expands-biomarker-development-capabilities-with-installation-of-DNA-mass-sequencer.aspx)